摘要
目的探讨胸腺瘤新WHO组织学分型与临床病理特征之间的关系。方法对53例胸腺瘤按WHO(2004)组织学分型标准分类,同时总结胸腺瘤患者的临床资料并分析组织学分型与临床特征的关系。结果胸腺瘤A型2例,AB型11例,B1型16例,B2型4例,B3型20例;Masaoka临床分期,Ⅰ期19例,Ⅱ期19例,Ⅲ期3例,Ⅳ期12例。WHO组织学分型与临床分期的相关性有统计学意义(P<0.005)。结论WHO组织学分型能反映其生物学行为和临床分期及评价患者的预后。
Objective To investigate the relationship between the new WHO histological classification and clinicopathological characteristics. Methods According to the new WHO histological classification system, this study group the 53 cases of thymoma, summarize the clinic dates and analysize the relationship between histological classification and clinic characteris,tics. Results 2 cases in type A, 11 cases in type AB, 16 cases in type B1, 4 cases in type B2, 20 cases in type B3. According to Masaoka clinical stages, there were 19 cases in stage Ⅰ , 19 cases in stage Ⅱ , 3 cases in stage Ⅲ, 12 cases in stage Ⅳ. WHO histological classification was significantily correlatied to clinical stages （P〈0. 005）. Conclusion WHO histological classification in thymoma can reflect the biological behaviors and clinical stages and can evaluate the patient＇s prognosis.
出处
《福建医药杂志》
CAS
2007年第3期10-11,共2页
Fujian Medical Journal
关键词
胸腺瘤
组织学分型
临床分期
Thymoma
Histological classification
Clinical stages
